Kei-Ichi Ishikawa (Nobutaka Hattori)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Subarachnoid Hemorrhage

Quality Control

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Date, Yukiko Sasazawa, Mitsuhiro Kitagawa, Kentaro Gejima, Ayami Suzuki, Hideyuki Saya, Yasuyuki Kida, Masaya Imoto, Eisuke Itakura, Kei-Ichi Ishikawa, Shinji Saiki
Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease. eLife 13 (2024)
Yuki Date, Yukiko Sasazawa, Mitsuhiro Kitagawa, Kentaro Gejima, Ayami Suzuki, Hideyuki Saya, Yasuyuki Kida, Masaya Imoto, Eisuke Itakura, Kei-Ichi Ishikawa, Shinji Saiki
Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease. eLife 13 (2024)
Yuki Date, Yukiko Sasazawa, Mitsuhiro Kitagawa, Kentaro Gejima, Ayami Suzuki, Hideyuki Saya, Yasuyuki Kida, Masaya Imoto, Eisuke Itakura, Kei-Ichi Ishikawa, Shinji Saiki
Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease. eLife 13 (2024)
Yuki Date, Yukiko Sasazawa, Mitsuhiro Kitagawa, Kentaro Gejima, Ayami Suzuki, Hideyuki Saya, Yasuyuki Kida, Masaya Imoto, Eisuke Itakura, Kei-Ichi Ishikawa, Shinji Saiki
Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease. eLife 13 (2024)
Satoru Torii, Satoko Arakawa, Shigeto Sato, Kei-Ichi Ishikawa, Daisuke Taniguchi, Hajime Tajima Sakurai, Shinya Honda, Yuuichi Hiraoka, Masaya Ono, Wado Akamatsu, Nobutaka Hattori, Shigeomi Shimizu
Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2. EMBO molecular medicine (2023)